Search for: "BRISTOL-MYERS SQUIBB" Results 341 - 360 of 863
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Sep 2015, 8:40 am by Law Offices of Jeffrey S. Glassman
One of the four drugs is Eliquis, manufactured by Bristol-Myers Squibb (BMS), and, according to recent article from Forbes, the drugmaker has a lot riding on Eliquis sales. [read post]
3 Sep 2015, 7:34 am by Law Offices of Jeffrey S. Glassman
Eliquis, manufactured by Bristol-Myers Squibb (BMS) and Pfizer, is now claiming its new oral anticoagulant (NOAC) is safer than other NOACs (Xarelto, Pradaxa, and Savaysa), according to a recent news article from Medpage Today. [read post]
30 Aug 2015, 9:53 pm by Patent Docs
Bristol-Myers Squibb Co. et al. v. [read post]
25 Aug 2015, 10:55 am by Duets Guest Blogger
The cases of Bristol-Myers Squibb v Paranova and Boehringer II in particular held that where a parallel importer re-packages goods, the following conditions must be satisfied to prevent infringement: The repacking must be objectively necessary to avoid market partitioning; The condition of the product must not be effected; The manufacturer and the importer must be clearly identified; The reputation of the mark and its owner must not be damaged; and The importer must give… [read post]
20 Aug 2015, 4:52 pm by David Jensen
HighlightsCreating pathway to clinicThe Calibr approachProblematic pharma-academic tiesAs of today, the California stem cell agency has a $4 million hook into a San Diego research enterprise that also has ties to a glittering array of partners, ranging from Merck to Bristol-Myers Squibb. [read post]
4 Aug 2015, 3:30 am by Steve Brachmann
Bristol-Myers Squibb was able to move on in clinical trials of its cancer drug Opvido more quickly than anticipated after kidney cancer patients who were administered the medication showed superior overall survival compared to those patients who were not on an Opvido regimen. [read post]
19 Jul 2015, 5:09 pm by Sabrina I. Pacifici
Bristol-Myers Squibb, No. 26, is selling an immunotherapy drug that is saving the lives of people with skin and lung cancer…” Nanette Byrnes [read post]
9 Jul 2015, 3:28 pm by Dr. Shezad Malik
Xarelto, has grabbed a 32 percent market share in the highly competitive anticoagulant market, significantly ahead of Boehringer’s Pradaxa and Bristol-Myers Squibb’s Eliquis, the other two new anticoagulants in the market. [read post]
5 Jul 2015, 9:42 am by Schachtman
Bristol-Myers Squibb sought and obtained a commission in state court (New Jersey) cases for a Massachusetts’ subpoena for Garrido’s underlying data late in1997. [read post]
26 Jun 2015, 11:30 am
  Our readers already know that it took the California Supreme Court less than four months to depublish Bristol-Myers Squibb (reported here). [read post]
19 Jun 2015, 6:30 am by Michael B. Stack
Food and Drug Administration (FDA) approved the first AB-rated generics to Bristol-Myers Squibb and Otsuka’s Abilify® (aripiprazole) tablets, an atypical antipsychotic drug commonly used for treating schizophrenia and bipolar disorder. [read post]
10 Jun 2015, 6:28 pm
Our client started working for Bristol-Myers Squibb in 1989 – staying with the company until she became disabled in November 2010. [read post]
12 May 2015, 3:26 pm by James Galvin
., Inc. 902619386 UBS Yield Optimization Notes with Contingent Protection linked to General Electric Company 902619394 UBS Yield Optimization Notes with Contingent Protection linked to Exxon Mobil Corp. 902619493 UBS Yield Optimization Notes with Contingent Protection linked to Texas Instruments Inc 902619519 UBS Yield Optimization Notes with Contingent Protection linked to Amgen Inc. 902619527 UBS Yield Optimization Notes with Contingent Protection linked to Goldcorp Inc. 902619535 UBS Yield… [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
13 Apr 2015, 3:00 am by Steve Brachmann
There’s been a lot of positive activity in recent months for Bristol-Myers Squibb of New York City. [read post]
13 Apr 2015, 3:00 am by Steve Brachmann
There’s been a lot of positive activity in recent months for Bristol-Myers Squibb of New York City. [read post]